Levofloxacin Infusion bulk supplier for pharma manufacturers

Levofloxacin Infusion Suppliers & Bulk Manufacturers

Available Forms: IV Infusion

Available Strengths: 250 mg/50 mL, 500 mg/100 mL, 750 mg/150 mL

Reference Brands: Levaquin(US & EU), Tavanic(EU), Levoflox (India/LATAM)

Levofloxacin is a powerful fluoroquinolone antibiotic used for respiratory, urinary, and skin infections. Available in tablets, oral solution, and IV forms in the US and EU under brands like Levaquin® and Tavanic®, it's ideal for B2B, PCD, and global pharma markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Levofloxacin is a broad-spectrum fluoroquinolone antibiotic widely used to treat respiratory tract infections, urinary tract infections, sinusitis, and skin infections. Available in the US and EU, it comes in tablets (250 mg, 500 mg, 750 mg), oral solution (25 mg/mL), and intravenous (IV) infusions. Marketed under brand names like Levaquin® and Tavanic®, along with generics, it offers potent bacterial coverage with once-daily dosing convenience. Levofloxacin is highly sought after in B2B, PCD franchise, and export markets due to its wide clinical use and proven efficacy. It is a staple in global pharmaceutical supply chains for treating common infections.

Levofloxacin Infusion — third party manufacturing & bulk supply

Levofloxacin Infusion is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Levofloxacin Infusion is supplied as IV Infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Levofloxacin Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Levofloxacin Infusion →

Back to Listing

Frequently Asked Questions

Levofloxacin Infusion is used to treat a wide range of bacterial infections caused by susceptible organisms. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and certain types of prostatitis. The intravenous infusion form is typically used in hospital settings when oral administration is not feasible or when rapid therapeutic levels are required.

Levofloxacin Infusion contains the active pharmaceutical ingredient levofloxacin, a third-generation fluoroquinolone antibiotic. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair, thereby preventing bacterial growth and proliferation.

Levofloxacin Infusion is marketed under various trade names worldwide, including Levaquin, Tavanic IV, and generic levofloxacin IV formulations depending on the manufacturer and region.

Levaquin is manufactured by Johnson & Johnson. Other pharmaceutical companies, including Sandoz, Cipla, and Mylan / Viatris, also produce generic levofloxacin infusion for global markets.

The generic name of Levofloxacin Infusion is levofloxacin.

Common brand names include Levaquin, Tavanic IV, and various generic formulations.

Levofloxacin Infusion is manufactured in several countries including the United States, India, China, and multiple European countries by different pharmaceutical companies producing both branded and generic formulations for global distribution.